{"id":233525,"date":"2025-09-29T00:00:00","date_gmt":"2025-09-29T00:00:00","guid":{"rendered":"http:\/\/clarivate.com\/life-sciences-healthcare\/report\/47041111-medtech-heart-valve-devices-market-insights-europe\/"},"modified":"2026-04-24T11:05:48","modified_gmt":"2026-04-24T11:05:48","slug":"47042578-medtech-heart-valve-devices-market-insights-europe","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/47042578-medtech-heart-valve-devices-market-insights-europe\/","title":{"rendered":"Heart Valve Devices &#8211; Market Insights &#8211; Europe"},"content":{"rendered":"<p>The European heart valve device market will continue to observe <span>moderate<\/span> growth, particularly due to growing demand for minimally invasive cardiac interventions boosting the adoption of <abbr title=\"Transcatheter Heart Valve\">THV<\/abbr> devices. Positive clinical outcomes, along with favourable regulatory frameworks and evolving reimbursement policies, are facilitating faster market entry for new <abbr title=\"Transcatheter Heart Valve\">THV<\/abbr> technologies.<\/p>\n<p>This Medtech 360 Report provides comprehensive data and analysis on the state of the market for heart valve devices in Europe from 2019 through 2034.<\/p>\n<p><strong>The competitive landscape for the <abbr title=\"Transcatheter Heart Valve\">THV<\/abbr> device market is evolving. <\/strong><\/p>\n<p>Which competitors have the most diverse portfolios in the heart valve device space?<\/p>\n<p>How has the preference for transcatheter and surgical valve treatment shifted with recent clinical results and market conditions?<\/p>\n<p>How are companies gaining competitive edge through mergers and acquisitions?<\/p>\n<p><strong>N<\/strong><strong>ovel <abbr title=\"Transcatheter Heart Valve\">THV<\/abbr> technologies, including <abbr title=\"Transcatheter Tricuspid Valve Implantation\">TTVI<\/abbr>, <abbr title=\"Transcatheter Mitral Valve Implantation\">TMVI<\/abbr> and <abbr title=\"Transcatheter Tricuspid Valve Repair\">TTVR<\/abbr>, will drive the expansion of European heart valve device market.<\/strong><\/p>\n<p>How will the approval of <abbr title=\"Transcatheter Tricuspid Valve Repair\">TTVR<\/abbr> and <abbr title=\"Transcatheter Mitral Valve Implantation\">TMVI<\/abbr> devices impact the European heart valve devices market?<\/p>\n<p>Which new <abbr title=\"Transcatheter Heart Valve\">THV<\/abbr> devices are going to enter the market? How will they impact the market?<\/p>\n<p>What&#8217;s the competitive landscape of the <abbr title=\"Transcatheter Mitral Valve Repair\">TMVR<\/abbr> device space, with long-established MitraClip and emerging <abbr title=\"Transcatheter Mitral Valve Repair\">TMVR<\/abbr> devices?<\/p>\n<p>How will the <abbr title=\"Transcatheter Tricuspid Valve Implantation\">TTVI<\/abbr> market grow over the forecast period?<\/p>\n<p><strong>Clinical trial results play an important factor in the heart valve device market.<\/strong><\/p>\n<p>Which segments have been the most impacted by clinical results?<\/p>\n<p>Which novel devices have been approved or have failed to gain approval due to data from clinical trials?<\/p>\n<p class=\"question-statement\">How will innovations currently being developed and evaluated in clinical trials affect changes in market share dynamics?<\/p>\n<p class=\"question-statement\"><b>Market leaders in the European heart valve device market are consolidating or capturing sales and improving market shares by acquiring smaller competitors.<\/b><\/p>\n<p>What effect have mergers and acquisitions had on this market?<\/p>\n","protected":false},"template":"","class_list":["post-233525","report","type-report","status-publish","hentry","report-gateway-medtech","medtech-therapy-area-cardiovascular","medtech-therapy-area-heart-valve-devices","medtech-geography-europe","medtech-date-2294"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/233525","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":3,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/233525\/revisions"}],"predecessor-version":[{"id":539778,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/233525\/revisions\/539778"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=233525"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}